Back to Search
Start Over
Pembrolizumab in HER2-Positive Gastric Cancer.
- Source :
-
The New England journal of medicine [N Engl J Med] 2024 Oct 10; Vol. 391 (14), pp. 1360-1362. Date of Electronic Publication: 2024 Sep 14. - Publication Year :
- 2024
- Subjects :
- Female
Humans
Double-Blind Method
Antineoplastic Combined Chemotherapy Protocols
Progression-Free Survival
Trastuzumab therapeutic use
Male
Middle Aged
Aged
Esophagogastric Junction pathology
Antibodies, Monoclonal, Humanized therapeutic use
Antineoplastic Agents, Immunological therapeutic use
Antineoplastic Agents, Immunological adverse effects
Receptor, ErbB-2 analysis
Receptor, ErbB-2 metabolism
Stomach Neoplasms drug therapy
Stomach Neoplasms mortality
Stomach Neoplasms pathology
Adenocarcinoma drug therapy
Adenocarcinoma mortality
Adenocarcinoma pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1533-4406
- Volume :
- 391
- Issue :
- 14
- Database :
- MEDLINE
- Journal :
- The New England journal of medicine
- Publication Type :
- Report
- Accession number :
- 39282917
- Full Text :
- https://doi.org/10.1056/NEJMc2408121